Search for Clinical Trial Results

Sponsored By

Proteinuria - 23 Studies Found

Status Study
Completed Study Name: To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Condition:
  • Microalbuminuria
  • Proteinuria

Date: 2007-10-24
Interventions: Drug: valsartan
Completed Study Name: The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria
Condition:
  • Chronic Kidney Disease
  • Proteinuria

Date: 2012-02-11
Interventions: Drug: aliskiren, eplerenon, telmisartan aliskiren (Rasilez 300 mg, Novartis Europharm eplerenon (Inspra
Completed Study Name: Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients
Condition:
  • Disorder of Transplanted Kidney
  • Proteinuria
  • Drug: Paricalcitol 2 microgram
Completed Study Name: Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
Condition:
  • Diabetes
  • Proteinuria

Date: 2007-06-27
Interventions: Drug: N-acetylcysteine(Mucomyst)
Completed Study Name: Influence of Aliskiren on Proteinuria
Condition:
  • Chronic Kidney Disease
  • Proteinuria
  • Proteinuria
  • Hypertension
  • End
    Date: 2006-08-28
    Interventions:
    • Drug: losartan, hydrochlorothiazide

Completed Study Name: Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose
Condition: We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
Date: 2012-11-28
Interventions: Drug: Amlodipine 10 mg/day for 12 weeks
Completed Study Name: Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
Condition:
  • PROTEINURIA
  • Hypertension
  • Type
    Date: 2005-10-14
    Interventions: Drug: valsartan
Withdrawn Study Name: The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria
Condition:
  • Systemic Lupus Erythematosus
  • Nephritis
  • Drug: Calcitriol Patients will
Completed Study Name: Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria
Condition:
  • Lupus Nephritis
  • Proteinuria
  • C
    Date: 2009-07-08
    Interventions: Drug: tripterygium glycosides The onset dosage should be 30mg/q.d. and can be reduced into 20mg b.i.d if
<<< Previous | Next >>>